title: [Beneficial effect of cisplatin based combination chemotherapy on adenocarcinoma of the lung].
abstract: Cisplatin (CDDP) based combination chemotherapy has improved the response rate of non-small cell lung cancer (NSCLC). However, the survival benefit of CDDP-based chemotherapy in patients with NSCLC is still controversial. In order to determine whether CDDP had a meaningful impact on the course of NSCLC, the survival of patients treated by combination chemotherapy containing CDDP (CDDP arm: PVB; CDDP + vindesine + bleomycin, VIP; vindesine + ifosfamide + CDDP) was compared with that treated by chemotherapy without CDDP (no CDDP arm: COMP; cyclophosphamide + vincristine + methotrexate + procarbazine, MVB; mitomycin C + vindesine + bleomycin), retrospectively. Survival in CDDP arm (median survival time [MST]; 10.2 months) was significantly longer than in the no-CDDP arm (MST; 6.9 months) (p less than 0.01). These results indicate that CDDP-based combination chemotherapy can not only improve response rate but also prolong survival of NSCLC.
authors: Second Dept. of Internal Medicine, Okayama University Medical School.
authors: H
authors: H
authors: Ueoka
authors: T
authors: T
authors: Ohnoshi
authors: T
authors: T
authors: Numata
authors: S
authors: S
authors: Kawahara
authors: K
authors: K
authors: Nishii
authors: T
authors: T
authors: Yonei
authors: H
authors: H
authors: Yamashita
authors: J
authors: J
authors: Ishii
authors: T
authors: T
authors: Moritaka
authors: K
authors: K
authors: Kiura
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy* / Q000401:mortality; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage; D002945:Cisplatin / Q000008:administration & dosage*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D012189:Retrospective Studies; D015996:Survival Rate; D014751:Vindesine / Q000008:administration & dosage
chemical_list: D001761:Bleomycin; D002945:Cisplatin; D014751:Vindesine; D007069:Ifosfamide